1. Stocks
  2. Bliss GVS Pharma Ltd.
  3. Swot
swot-logo

Bliss GVS Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Bliss GVS Pharma Ltd. has 19 Strengths, 6 Weaknesses, 3 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Strong Performer, Under Radar Stocks (DVM)

Strong Momentum: Price above short, medium and long term moving averages

Consistent Highest Return Stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Affordable Stocks - Stocks with Good Trendlyne Valuation Score

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

Top Gainers

Insiders bought stocks

Companies with growing costs YoY for long term projects

Decline in Quarterly Net Profit (YoY)

Declining Revenue every quarter for the past 2 quarters

Declining profits every quarter for the past 2 quarters

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Increased Shareholding in Past Month

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Promoters increasing shareholding QoQ

Rising Delivery Percentage Compared to Prev Day

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)